LncRNA THEMIS2‐211, a tumor‐originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA-Reference-Cited by-同舟云学术

LncRNA THEMIS2‐211, a tumor‐originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA

Published:2022-02-28 Issue:4 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Yao Jiyou¹,Hua Xuefeng¹,Shi Jiewei¹,Hu Xiaoyuan¹,Lui Kayin²,He Kaitao¹,Mai Jialuo¹,Lan Tian³,Lu Minqiang¹^ORCID

Affiliation:

1. Department of HBP SURGERY II the Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou People's Republic of China

2. The First Affiliated Hospital of Sun Yat‐sen University Guangzhou People's Republic of China

3. Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine Guangdong Pharmaceutical University Guangzhou People's Republic of China

Funder

Guangzhou Municipal Science and Technology Project

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202101564R

Reference62 articles.

1. Hepatocellular carcinoma

2. Predictors of 5 year survival rate in hepatocellular carcinoma patients

3. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma